{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-012238","form_type":"8-K","ticker":"MYO","cik":"0001369290","company_name":"MYOMO, INC.","filed_at":"2023-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.588348+00:00","generated_at":"2026-06-17T04:02:26.551275+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Myomo receives $1.7M final license fee from China JV, enabling MyoPro manufacturing and sales in China","bullets":["Received final $1.7M of initial license fee from Jiangxi Myomo JV; total upfront fee now $2.7M.","Enables start of technology transfer to JV for MyoPro manufacture and sale in China, Hong Kong, Taiwan, Macau.","JV committed to purchase at least $10.75M in MyoPro Control System Units over 10 years, subject to regulatory approvals.","Myomo owns 19.9% of JV; majority partner is Anhui Ryzur Medical Equipment Manufacturing.","Payment will be recognized as license revenue in Q2 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-012238","json":"https://secwatch.observer/filing/0000950170-23-012238.json","markdown":"https://secwatch.observer/filing/0000950170-23-012238.md","text":"https://secwatch.observer/filing/0000950170-23-012238.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369290/000095017023012238/0000950170-23-012238-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369290/000095017023012238/myo-20230406.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T04:02:26.551275+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}